+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID05709782

Phase II Study of Spinal Stereotactic Radiotherapy Using MR-LINAC for Spine Disease Treatment

Led by M.D. Anderson Cancer Center · Updated on 2026-07-21

40

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether spinal stereotactic radiosurgery SRSS using a new imaging method, Magnetic Resonance Imaging with a Linear Accelerator MR-LINAC, can improve treatment response and quality of life for patients with spinal disease. This Phase II study focuses on controlling tumor growth in the spine and measuring patient symptoms over time. Participants are randomly assigned to one of two groups. One group receives spine radiosurgery using the MR-LINAC machine, which includes advanced imaging scans with the same device. The other group receives spine radiosurgery with a standard radiation machine and may also have imaging done using the MR-LINAC. Treatments target spinal tumors and involve radiation delivered to up to three contiguous vertebral levels. During the study, participants complete symptom questionnaires related to their spine tumor up to one year after treatment. Researchers also assess how well the treatment controls tumor growth at 6 months and 1 year, and monitor changes in tumor size. The study includes regular imaging and clinical evaluations to track safety and effectiveness, with participation lasting up to the study completion date in early 2029.

CONDITIONS

Brief Title

Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC

Research Team

D

Debra N. Yeboa, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here